Lack of increase in vancomycin resistance of pediatric methicillin- resistant staphylococcus aureus isolates from 2000 to 2007

Pediatric Infectious Disease Journal

Volumn 29, Issue 9, 2010, Pages 882-884

  Zheng, Xiaotian ^a,b   Qi, Chao ^b,c   Arrieta, Mollyn ^a   O'Leary, Amanda ^a   Wang, Deli ^a,b   Shulman, Stanford T ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

D zone test; inducible clindamycin resistance; MRSA; pediatric; vancomycin

Indexed keywords

CLINDAMYCIN; VANCOMYCIN;

AGAR DIFFUSION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 77955985432     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181e284a6     Document Type: Article

References (12)

1. Seinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-sus- ceptable clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-2005. J Antimicrob Chemother. 2007;60:788-794.
2. Wang G, Hindler JF, Ward KW, et al. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol. 2006;44:3883-3886.
3. Alos JI, Garcia-Canas A, Garcia-Hierro P, et al. Vancomycin MICs did not creep in Staphylococcus aureus isolated from 2002 to 2006 in a setting with low vancomysin usage. J Antimicrob Chemother. 2008;62:773-775.
4. Holmes RL, Jorgensen JH. Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006. Antimicrob Agents Chemother. 2008;52:757-760.
5. Stevens DL. The role of vancomycin in the treatment paradigm. Clin Infect Dis. 2006;42:S51-S57.
6. Prakash V, Lewis JS II, Jorgensen JH. Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother. 2008;52:4528.
7. McDougal LK, Steward CD, Killgore GE, et al. Pulsed-Field Gel Electro-phoresis typing of Oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113-5120.
8. Huang SS, Diekema DJ, Warren DK, et al. Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis. 2008;46:1241-1247.
9. Mason EO, Lamberth LB, Hammerman WA, et al. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol. 2009;47:1628-1630.
10. Bae IG, Federspiel JJ, Miro JM, et al. Heterogeneous vancomycin-inter- mediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance. J Infect Dis. 2009;200:1355-1366.
11. Horne KC, Howden BP, Grabsch EA, et al. Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother. 2009;53:3447-3452.
12. Tenover FC, McDougal LK, Goering RV, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol. 2006;44:108-118.